Spondyloarthritis: a window of opportunity?

Joint Bone Spine. 2014 May;81(3):197-9. doi: 10.1016/j.jbspin.2014.02.008. Epub 2014 May 1.

Author

Pascal Claudepierre¹

Affiliation

¹ Université Paris Est Créteil, Laboratoire d'Investigation Clinique (LIC) EA4393, 94010 Créteil, France; AP-HP, Hôpital Henri-Mondor, Service de Rhumatologie, 51, avenue Maréchal-de-Lattre-de-Tassigny, 94010 Créteil, France. Electronic address: pascal.claudepierre@hmn.aphp.fr.

PMID: 24793087
DOI: 10.1016/j.jbspin.2014.02.008

No abstract available

Keywords: Ankylosing spondylarthritis; Early treatment; Spondyloarthritis; Window of opportunity.

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Anti-Inflammatory Agents / administration & dosage
Disease Progression
Early Diagnosis
Humans
Inflammation / diagnosis
Inflammation / drug therapy
Magnetic Resonance Imaging
Prognosis
Spondylarthritis / diagnosis*
Spondylarthritis / drug therapy
Tumor Necrosis Factor-alpha / antagonists & inhibitors

Substances

Anti-Inflammatory Agents
Tumor Necrosis Factor-alpha